This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Repros Therapeutics Inc (RPRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 21.39M 46.62M 75.81M 24.21M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 21.48M 46.91M 76.00M 24.62M
Property, Plant & Equipment, Gross 216.00K 216.00K 216.00K 154.00K
Accumulated Depreciation & Depletion 208.00K 184.00K 141.00K 101.00K
Property, Plant & Equipment, Net 8.00K 32.00K 75.00K 53.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 2.91M 2.16M
Total Non-Current Assets 8.00K 32.00K 2.98M 2.21M
Liabilities & Shareholder Equity
Total Assets 21.48M 46.94M 78.98M 26.83M
Accounts Payable 1.97M 2.09M 2.97M 3.24M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 2.92M 2.92M 3.55M 3.80M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 0.00 0.00
Total Liabilities 2.92M 2.92M 3.55M 3.80M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 18.57M 44.02M 75.42M 23.03M
Common Par 24.00K 24.00K 23.00K 17.00K
Additional Paid In Capital 322.18M 318.44M 314.40M 234.30M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -302.26M -273.06M -237.62M -209.90M
Treasury Stock -1.38M -1.38M -1.38M -1.38M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 18.57M 44.02M 75.42M 23.03M
Total Equity 18.57M 44.02M 75.42M 23.03M
Total Liabilities & Stock Equity 21.48M 46.94M 78.98M 26.83M
Total Common Shares Outstanding 24.32M 24.28M 23.01M 17.16M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 112.35K 112.35K 112.35K 112.35K
Basic Weighted Shares Outstanding 24.30M 23.43M 20.81M 15.35M
Diluted Weighted Shares Outstanding 24.30M 23.43M 20.81M 15.35M
Number of Employees 26 28 25 21
Number of Part-Time Employees 0 0 0 0
RPRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RPRX Repros Therapeutics Inc

Chart of RPRX

Analysts Ratings for RPRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET RPRX ANALYST REPORT

RPRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs